Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study von Alferink, Louise JM, Kiefte-de Jong, Jessica C, Erler, Nicole S, Veldt, Bart J, Schoufour, Josje D, de Knegt, Robert J, Ikram, M Arfan, Metselaar, Herold J, Janssen, Harry LA, Franco, Oscar H, Darwish Murad, Sarwa

Volltext

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B von Jang, Heejoon, Yoon, Jun Sik, Park, Soo Young, Lee, Han Ah, Jang, Myoung-jin, Kim, Seung Up, Sinn, Dong Hyun, Seo, Yeon Seok, Kim, Hwi Young, Kim, Sung Eun, Jun, Dae Won, Yoon, Eileen L., Sohn, Joo Hyun, Ahn, Sang Bong, Shim, Jae-Jun, Jeong, Soung Won, Cho, Yong Kyun, Kim, Hyoung Su, Nam, Joon Yeul, Lee, Yun Bin, Kim, Yoon Jun, Yoon, Jung-Hwan, Zoulim, Fabien, Lampertico, Pietro, Dalekos, George N., Idilman, Ramazan, Sypsa, Vana, Berg, Thomas, Buti, Maria, Calleja, Jose Luis, Goulis, John, Manolakopoulos, Spilios, Janssen, Harry LA, Papatheodoridis, George V., Lee, Jeong-Hoon

Volltext

The role of quantitative hepatitis B surface antigen revisited von Cornberg, Markus, Wong, Vincent Wai-Sun, Locarnini, Stephen, Brunetto, Maurizia, Janssen, Harry L.A, Chan, Henry Lik-Yuen

Volltext

How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? von Rajoriya, Neil, Combet, Christophe, Zoulim, Fabien, Janssen, Harry L.A.

Volltext

New therapeutic opportunities for hepatitis C based on small RNA von Pan, Qiu-Wei, Henry, Scot D, Scholte, Bob J, Tilanus, Hugo W, Janssen, Harry L A, van der Laan, Luc J W

Volltext

Treatment of HCV Infection by Targeting MicroRNA von Janssen, Harry L.A, Reesink, Hendrik W, Lawitz, Eric J, Zeuzem, Stefan, Rodriguez-Torres, Maribel, Patel, Keyur, van der Meer, Adriaan J, Patick, Amy K, Chen, Alice, Zhou, Yi, Persson, Robert, King, Barney D, Kauppinen, Sakari, Levin, Arthur A, Hodges, Michael R

Volltext

IDDF2021-ABS-0079 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (C... von Lim, Young-Suk, Lin, Chun-Yen, Heo, Jeong, Bae, Ho, Chuang, Wan-Long, Yin Owen Tsang, Tak, Fournier, Claire, Hui, Aric Josun, Trinh, Huy, Yee Kwan Chan, Carol, Tan, Susanna K, Zhao, Yang, Flaherty, John F, Suri, Vithika, Gaggar, Anuj, Brainard, Dianna M, Ryder, Stephen, Janssen, Harry LA

Volltext

IDDF2020-ABS-0061 Impact of treatment with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic h... von Yuen Chan, Henry Lik, Lim, Young-Suk, Seto, Wai Kay, Ning, Qin, Agarwal, Kosh, Janssen, Harry LA, Pan, Calvin O, Chuang, Wan Long, Izumi, Namiki, Fung, Scott, Brunetto, Maurizia, Flaherty, John, Mo, Shuyuan, Cheng, Cong, Lin, Lanjia, Gaggar, Anuj, Subramanian, Mani, Marcellin, Patrick, Gane, Edward, Hou, Jinlin, Buti, Maria

Volltext

IDDF2021-ABS-0078 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (C... von Janssen, Harry LA, Lampertico, Pietro, Chen, Chien-Hung, Heo, Jeong, Fournier, Claire, Ahn, Sang Hoon, Yin Owen Tsang, Tak, Coffin, Carla S, Huang, Yi-Hsang, Marchesini, Giulio, Hui, Aric Josun, Elkhashab, Magdy, Jafri, Sayed-Mohammed, Yee Kwan Chan, Carol, Tan, Susanna K, Zhao, Yang, Suri, Vithika, Flaherty, John F, Gaggar, Anuj, Brainard, Diana, Chuang, Wan-Long, Agarwal, Kosh, Gane, Edward, Lim, Young-Suk

Volltext

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis von Fan, Rong, Papatheodoridis, George, Sun, Jian, Innes, Hamish, Toyoda, Hidenori, Xie, Qing, Mo, Shuyuan, Sypsa, Vana, Guha, Indra Neil, Kumada, Takashi, Niu, Junqi, Dalekos, George, Yasuda, Satoshi, Barnes, Eleanor, Lian, Jianqi, Suri, Vithika, Idilman, Ramazan, Barclay, Stephen T., Dou, Xiaoguang, Berg, Thomas, Hayes, Peter C., Flaherty, John F., Zhou, Yuanping, Zhang, Zhengang, Buti, Maria, Hutchinson, Sharon J., Guo, Yabing, Calleja, Jose Luis, Lin, Lanjia, Zhao, Longfeng, Chen, Yongpeng, Janssen, Harry L.A., Zhu, Chaonan, Shi, Lei, Tang, Xiaoping, Gaggar, Anuj, Wei, Lai, Jia, Jidong, Irving, William L., Johnson, Philip J., Lampertico, Pietro, Hou, Jinlin

Volltext

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genot... von SONNEVELD, Milan J, RIJCKBORST, Vincent, LA JANSSEN, Harry, CAKALOGLU, Yilmaz, SIMON, Krzysztof, HEATHCOTE, E. Jenny, TABAK, Fehmi, MACH, Tomasz, AB BOUCHER, Charles, HANSEN, Bettina E, ZEUZEM, Stefan

Volltext

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis von Sharma, Suraj A., Kowgier, Matthew, Hansen, Bettina E., Brouwer, Willem Pieter, Maan, Raoel, Wong, David, Shah, Hemant, Khalili, Korosh, Yim, Colina, Heathcote, E. Jenny, Janssen, Harry L.A., Sherman, Morris, Hirschfield, Gideon M., Feld, Jordan J.

Volltext

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis von Harms, Maren H., van Buuren, Henk R., Corpechot, Christophe, Thorburn, Douglas, Janssen, Harry L.A., Lindor, Keith D., Hirschfield, Gideon M., Parés, Albert, Floreani, Annarosa, Mayo, Marlyn J., Invernizzi, Pietro, Battezzati, Pier Maria, Nevens, Frederik, Ponsioen, Cyriel Y., Mason, Andrew L., Kowdley, Kris V., Lammers, Willem J., Hansen, Bettina E., van der Meer, Adriaan J.

Volltext

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection von Agarwal, Kosh, Brunetto, Maurizia, Seto, Wai Kay, Lim, Young-Suk, Fung, Scott, Marcellin, Patrick, Ahn, Sang Hoon, Izumi, Namiki, Chuang, Wan–Long, Bae, Ho, Sharma, Manoj, Janssen, Harry L.A., Pan, Calvin Q., Çelen, Mustafa Kemal, Furusyo, Norihiro, Shalimar, Dr, Yoon, Ki Tae, Trinh, Huy, Flaherty, John F., Gaggar, Anuj, Lau, Audrey H., Cathcart, Andrea L., Lin, Lanjia, Bhardwaj, Neeru, Suri, Vithika, Mani Subramanian, G., Gane, Edward J., Buti, Maria, Chan, Henry L.Y.

Volltext

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication von van der Meer, Adriaan J, Feld, Jordan J, Hofer, Harald, Almasio, Piero L, Calvaruso, Vincenza, Fernández-Rodríguez, Conrado M, Aleman, Soo, Ganne-Carrié, Nathalie, D’Ambrosio, Roberta, Pol, Stanislas, Trapero-Marugan, Maria, Maan, Raoel, Moreno-Otero, Ricardo, Mallet, Vincent, Hultcrantz, Rolf, Weiland, Ola, Rutter, Karoline, Di Marco, Vito, Alonso, Sonia, Bruno, Savino, Colombo, Massimo, de Knegt, Robert J, Veldt, Bart J, Hansen, Bettina E, Janssen, Harry L.A

Volltext

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B von Papatheodoridis, George V., Sypsa, Vana, Dalekos, George N., Yurdaydin, Cihan, Van Boemmel, Florian, Buti, Maria, Calleja, Jose Luis, Chi, Heng, Goulis, John, Manolakopoulos, Spilios, Loglio, Alessandro, Voulgaris, Theodoros, Gatselis, Nikolaos, Keskin, Onur, Veelken, Rhea, Lopez-Gomez, Marta, Hansen, Bettina E., Savvidou, Savvoula, Kourikou, Anastasia, Vlachogiannakos, John, Galanis, Kostas, Idilman, Ramazan, Esteban, Rafael, Janssen, Harry L.A., Berg, Thomas, Lampertico, Pietro

Volltext

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B von Papatheodoridis, George V., Dalekos, George N., Idilman, Ramazan, Sypsa, Vana, Van Boemmel, Florian, Buti, Maria, Calleja, Jose Luis, Goulis, John, Manolakopoulos, Spilios, Loglio, Alessandro, Papatheodoridi, Margarita, Gatselis, Nikolaos, Veelken, Rhea, Lopez-Gomez, Marta, Hansen, Bettina E., Savvidou, Savvoula, Kourikou, Anastasia, Vlachogiannakos, John, Galanis, Kostas, Yurdaydin, Cihan, Esteban, Rafael, Janssen, Harry L.A., Berg, Thomas, Lampertico, Pietro

Volltext

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells von Nkongolo, Shirin, Mahamed, Deeqa, Kuipery, Adrian, Sanchez Vasquez, Juan D, Kim, Samuel C, Mehrotra, Aman, Patel, Anjali, Hu, Christine, McGilvray, Ian, Feld, Jordan J, Fung, Scott, Chen, Diana, Wallin, Jeffrey J, Gaggar, Anuj, Janssen, Harry LA, Gehring, Adam J

Volltext

Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study von Koehler, Edith M., Plompen, Elisabeth P.C., Schouten, Jeoffrey N.L., Hansen, Bettina E., Darwish Murad, Sarwa, Taimr, Pavel, Leebeek, Frank W.G., Hofman, Albert, Stricker, Bruno H., Castera, Laurent, Janssen, Harry L.A.

Volltext

Telaprevir/boceprevir era： From bench to bed and back von Pan, Qiuwei, Peppelenbosch, Maikel P, Janssen, Harry L A, de Knegt, Robert J

Volltext